H. R. 2130—5
SEC. 6. DEVELOPMENT OF MODEL PROTOCOLS, TRAINING MATERIALS,
FORENSIC FIELD TESTS, AND COORDINATION MECHA-
NISM 
FOR 
INVESTIGATIONS 
AND 
PROSECUTIONS
RELATING TO GAMMA HYDROXYBUTYRIC ACID, OTHER
CONTROLLED SUBSTANCES, AND DESIGNER DRUGS.
(a) IN GENERAL.—The Attorney General, in consultation with
the Administrator of the Drug Enforcement Administration and
the Director of the Federal Bureau of Investigation, shall—
(1) develop—
(A) model protocols for the collection of toxicology speci-
mens and the taking of victim statements in connection
with investigations into and prosecutions related to possible
violations of the Controlled Substances Act or other Federal
or State laws that result in or contribute to rape, other
crimes of violence, or other crimes involving abuse of
gamma hydroxybutyric acid, other controlled substances,
or so-called ‘‘designer drugs’’; and
(B) model training materials for law enforcement per-
sonnel involved in such investigations; and
(2) make such protocols and training materials available
to Federal, State, and local personnel responsible for such inves-
tigations.
(b) GRANT.—
(1) IN GENERAL.—The Attorney General shall make a grant,
in such amount and to such public or private person or entity
as the Attorney General considers appropriate, for the develop-
ment of forensic field tests to assist law enforcement officials
in detecting the presence of gamma hydroxybutyric acid and
related substances.
(2) AUTHORIZATION OF APPROPRIATIONS.—There are author-
ized to be appropriated such sums as may be necessary to
carry out this subsection.
(c) REPORT.—Not later than 180 days after the date of the
enactment of this Act, the Attorney General shall submit to the
Committees on the Judiciary of the Senate and House of Represent-
atives a report on current mechanisms for coordinating Federal,
State, and local investigations into and prosecutions related to
possible violations of the Controlled Substances Act or other Federal
or State laws that result in or contribute to rape, other crimes
of violence, or other crimes involving the abuse of gamma hydroxy-
butyric acid, other controlled substances, or so-called ‘‘designer
drugs’’. The report shall also include recommendations for the
improvement of such mechanisms.
SEC. 7. ANNUAL REPORT REGARDING DATE-RAPE DRUGS; NATIONAL
AWARENESS CAMPAIGN.
(a) ANNUAL REPORT.—The Secretary of Health and Human
Services (in this section referred to as the ‘‘Secretary’’) shall periodi-
cally submit to Congress reports each of which provides an estimate
of the number of incidents of the abuse of date-rape drugs (as
defined in subsection (c)) that occurred during the most recent
1-year period for which data are available. The first such report
shall be submitted not later than January 15, 2000, and subsequent
reports shall be submitted annually thereafter.
(b) NATIONAL AWARENESS CAMPAIGN.—
(1) DEVELOPMENT OF PLAN; RECOMMENDATIONS OF ADVISORY
COMMITTEE.—
H. R. 2130—6
(A) IN GENERAL.—The Secretary, in consultation with
the Attorney General, shall develop a plan for carrying
out a national campaign to educate individuals described
in subparagraph (B) on the following:
(i) The dangers of date-rape drugs.
(ii) The applicability of the Controlled Substances
Act to such drugs, including penalties under such Act.
(iii) Recognizing the symptoms that indicate an
individual may be a victim of such drugs, including
symptoms with respect to sexual assault.
(iv) Appropriately responding when an individual
has such symptoms.
(B) INTENDED POPULATION.—The individuals referred
to in subparagraph (A) are young adults, youths, law
enforcement personnel, educators, school nurses, counselors
of rape victims, and emergency room personnel in hospitals.
(C) ADVISORY COMMITTEE.—Not later than 180 days
after the date of the enactment of this Act, the Secretary
shall establish an advisory committee to make rec-
ommendations to the Secretary regarding the plan under
subparagraph (A). The committee shall be composed of
individuals who collectively possess expertise on the effects
of date-rape drugs and on detecting and controlling the
drugs.
(2) IMPLEMENTATION OF PLAN.—Not later than 180 days
after the date on which the advisory committee under para-
graph (1) is established, the Secretary, in consultation with
the Attorney General, shall commence carrying out the national
campaign under such paragraph in accordance with the plan
developed under such paragraph. The campaign may be carried
out directly by the Secretary and through grants and contracts.
(3) EVALUATION
BY
GENERAL
ACCOUNTING
OFFICE.—Not
later than 2 years after the date on which the national cam-
paign under paragraph (1) is commenced, the Comptroller Gen-
eral of the United States shall submit to Congress an evaluation
of the effects with respect to date-rape drugs of the national
campaign.
(c) DEFINITION.—For purposes of this section, the term ‘‘date-
rape drugs’’ means gamma hydroxybutyric acid and its salts, iso-
mers, and salts of isomers and such other drugs or substances
as the Secretary, after consultation with the Attorney General,
determines to be appropriate.
SEC. 8. SPECIAL UNIT IN DRUG ENFORCEMENT ADMINISTRATION FOR
ASSESSMENT OF ABUSE AND TRAFFICKING OF GHB AND
OTHER CONTROLLED SUBSTANCES AND DRUGS.
(a) ESTABLISHMENT.—Not later than 60 days after the date
of the enactment of this Act, the Attorney General shall establish
within the Operations Division of the Drug Enforcement Adminis-
tration a special unit which shall assess the abuse of and trafficking
in gamma hydroxybutyric acid, flunitrazepam, ketamine, other con-
trolled substances, and other so-called ‘‘designer drugs’’ whose use
has been associated with sexual assault.
(b) PARTICULAR DUTIES.—In carrying out the assessment under
subsection (a), the special unit shall—
H. R. 2130—7
(1) examine the threat posed by the substances and drugs
referred to in that subsection on a national basis and regional
basis; and
(2) make recommendations to the Attorney General
regarding allocations and reallocations of resources in order
to address the threat.
(c) REPORT ON RECOMMENDATIONS.—
(1) REQUIREMENT.—Not later than 180 days after the date
of the enactment of this Act, the Attorney General shall submit
to the Committees on the Judiciary of the Senate and House
of Representatives a report which shall—
(A) set forth the recommendations of the special unit
under subsection (b)(2); and
(B) specify the allocations and reallocations of resources
that the Attorney General proposes to make in response
to the recommendations.
(2) TREATMENT OF REPORT.—Nothing in paragraph (1) may
be construed to prohibit the Attorney General or the Adminis-
trator of the Drug Enforcement Administration from making
any reallocation of existing resources that the Attorney General
or the Administrator, as the case may be, considers appropriate.
SEC. 9. TECHNICAL AMENDMENT.
Section 401 of the Controlled Substances Act (21 U.S.C. 841)
is amended by redesignating subsections (d), (e), (f ), and (g) as
subsections (c), (d), (e), and (f ), respectively.
Speaker of the House of Representatives.
Vice President of the United States and
President of the Senate.